Quarter Period Consolidated Statement Of Comprehensive Income

Astellas Pharma Inc. - Filing #7332273

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
JPY
JPY
JPY
292,161,000,000 JPY
JPY
292,161,000,000 JPY
JPY
292,161,000,000 JPY
JPY
JPY
JPY
JPY
292,161,000,000 JPY
JPY
JPY
JPY
314,210,000,000 JPY
314,210,000,000 JPY
JPY
JPY
JPY
314,210,000,000 JPY
JPY
314,210,000,000 JPY
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.